Curis Inc (CRIS) stock

CRISNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 7/3091% below fair value

$0.57−0.02 (-3.33%)

Close on Nov 12, 2026Market cap $1.20MP/E –Yield –

Curis statistics

70 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Jun 30, 2026
Share price as of: Nov 12, 2026

Valuation ratiosIndustry

Market Cap: $1.20M; $280.48M
Enterprise Value: -$3.90M; $148.62M
PS Ratio: 0.28; 3.60
PB Ratio: 0.25; 2.05

Enterprise valuationIndustry

EV / Sales: -0.91; 2.60

Share statisticsIndustry

Shares Outstanding: 2M; 58M
Shares Change (YoY): 169.2%; 10.9%
Shares Change (QoQ): -2.50%; 0.51%
Float: 2M; 49M
Shares Held by Insiders: 20.4%; 12.1%
Shares Held by Institutions: 32.1%; 56.4%

Short sellingIndustry

Short Interest: 1M; –
Short Interest Change: 134.3%; -0.76%
Short % of Float: 61.8%; 9.04%
Short % of Shares Outstanding: 49.2%; 6.30%
Days to Cover: 1.12; 5.13

Stock price statisticsIndustry

52-Week High: $28.40; –
52-Week Low: $0.33; –
20-Day Moving Average: $0.58; –
50-Day Moving Average: $0.78; –
200-Day Moving Average: $8.23; –
Average True Range (14): $0.20; –
Price Change (1 Week): -32.7%; 1.51%
Price Change (1 Month): -4.67%; -2.35%
Price Change (3 Months): -68.2%; -21.1%
Price Change (6 Months): -94.4%; -22.6%
Price Change (YTD): -97.1%; -22.6%
Price Change (1 Year): -97.7%; -20.7%
Price Change (3 Years): -99.5%; -27.4%
Price Change (5 Years): -100.0%; -77.3%
Price Change (10 Years): -100.0%; -62.7%
Average Volume (10 Days): 24M; –
Average Volume (20 Days): 12M; –
Average Volume (90 Days): 3M; –
Relative Volume: 0.18; 0.79
Relative Strength Index (14): 43.4; 44.7
Volatility (1 Year): 147.3%; 80.4%
Beta (5 Years): 1.90; 1.07

MarginsIndustry

Operating Margin: -203.2%; -38.7%
Profit Margin: -490.3%; -32.0%
EBITDA Margin: -201.2%; -27.7%

Returns on capitalIndustry

Return on Assets (ROA): -87.8%; -40.6%
Return on Capital Employed (ROCE): -165.5%; -38.0%

Financial positionIndustry

Current Ratio: 0.49; 3.30
Quick Ratio: 0.37; 2.42

GrowthIndustry

Revenue Growth (YoY): -62.2%; 7.01%
Revenue Growth (3Y CAGR): -2.42%; 2.25%
Revenue Growth (5Y CAGR): -2.71%; 6.41%

EfficiencyIndustry

Asset Turnover: 0.18; 0.40
Revenue Per Employee: $179.75K; $429.29K
Profits Per Employee: -$881.38K; -$683.67K
Employee Count: 24; 75
WACC: 14.5%; 10.1%

Income statement (TTM)Industry

Revenue: $4.31M; $66.37M
Operating Income: -$8.76M; -$20.99M
Net Income: -$21.15M; -$21.61M
EBITDA: -$8.68M; -$16.85M

Balance sheetIndustry

Cash & Short-Term Investments: $5.10M; $67.63M
Net Cash (Debt): $5.10M; $17.46M
Net Cash Per Share: $2.44; $0.72
Equity (Book Value): $4.70M; $53.27M
Book Value Per Share: $2.25; $1.50
Tangible Book Value: -$4.29M; $26.82M
Working Capital: -$6.95M; $79.47M

Cash flow (TTM)Industry

Operating Cash Flow: -$30.59M; -$12.27M

Dividends and yieldsIndustry

Earnings Yield: -1770.0%; -20.8%
Buyback Yield: -2057.5%; -0.73%
Shareholder Yield: -2057.5%; 0.00%

Scores and fair valueIndustry

Altman Z-Score: -96.16; 0.30
Piotroski F-Score: 3; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

Period	CRIS	S&P 500	Difference	CRIS per year	S&P 500 per year
1 month	-11.1%	-2.7%	−8.4 pts
3 months	-65.8%	-1.7%	−64.0 pts
Year to date	-97.1%	+11.9%	−109.0 pts
1 year	-97.7%	+12.0%	−109.7 pts
3 years	-99.5%	+78.2%	−177.7 pts	-83.3%	+21.2%
5 years	-100.0%	+73.2%	−173.2 pts	-81.1%	+11.6%
10 years	-100.0%	+309.6%	−409.6 pts	-60.8%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

1M CRIS shares were sold short on Oct 30, 2026, up 134.3% from the previous report, or 61.83% of the shares available to trade. At recent volumes it would take 1.1 days to buy them back. Over the last 20 sessions, 53.7% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	1,029,348	+134.3%	917,258	1.1
Oct 15, 2026	439,270	+144.8%	224,716	1.9
Sep 30, 2026	179,462	+160.0%	176,280	1.0
Sep 15, 2026	69,025	-59.0%	126,957	1.0
Aug 31, 2026	168,213	-48.1%	177,225	1.0
Aug 14, 2026	324,276	+148.9%	481,898	1.0
Jul 31, 2026	130,308	+23.6%	72,697	1.8
Jul 15, 2026	105,458	-97.0%	111,499	1.0
Jun 30, 2026	3,515,828	+1242.5%	17,237,537	1.0
Jun 15, 2026	261,877	-7.7%	187,234	1.4
May 29, 2026	283,618	+3.7%	201,158	1.4
May 15, 2026	273,573	+4.3%	237,422	1.1